Company
Viking Therapeutics, Inc. (VKTX)
Standardized SEC financial data for Viking Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001607678 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-56.3%
Free cash flow
-$278.7M
Current ratio
9.33×
EPS (diluted)
$-3.19
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $29.1M | $26.4M | $36.6M | $55.5M | $26.7M | $165.8M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$21.8M | -$47.6M | -$48.4M | -$73.4M | -$87.8M | -$278.7M |
| Investing cash flow |
Get VKTX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/VKTX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/VKTX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"